Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cleary

Showing results (301-310 of 445) with videos related to

Pageof 45
Sort By:
Annals of Vascular Surgery|March 13, 2025
Use of Suboptimal Great Saphenous Vein in Lower-Extremity Bypass Yields Favorable Amputation-Free SurvivalColin M Cleary, James Gallagher, Parth Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)C P Duffy, C J Elliott, R A O'Connor, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 19, 2015
Changes in medical students' exposure to and attitudes about drug company interactions from 2003 to 2012: a multi-institutional follow-up surveyFrederick S Sierles, Kenneth H Kessler, Matthew Mintz, et al.
Protein Engineering, Design & Selection : PEDS|April 14, 2007
Molecular modeling suggests induced fit of Family I carbohydrate-binding modules with a broken-chain cellulose surfaceMark R Nimlos, James F Matthews, Michael F Crowley, et al.
Eclinicalmedicine|January 11, 2024
Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021)Daneng Li, Yohann Loriot, Adam M Burgoyne, et al.
JAMA|September 8, 2005
Medical students' exposure to and attitudes about drug company interactions: a national surveyFrederick S Sierles, Amy C Brodkey, Lynn M Cleary, et al.
Schizophrenia Research|September 29, 2014
A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolismBrenda Vincenzi, Shannon Stock, Christina P C Borba, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Replicative stress in gastroesophageal adenocarcinoma is associated with chromosomal instability and sensitivity to DNA damage response inhibitorsPranshu Sahgal, Deepa T Patil, Zsofia M Sztupinszki, et al.
Annals of Vascular Surgery|October 17, 2025
Utilization of Subsidized Transportation Services Improves Wound Healing and Care Coordination in a Limb Preservation ProgramColin M Cleary, Elizabeth Aitcheson, Darren Courtright, et al.
Journal of Community Health|June 29, 2023
Newly Acquired Burnout During the Coronavirus Disease 2019 (COVID-19) Pandemic: A Retrospective Cohort Study on the Experiences of New York State Primary Care CliniciansDean Akinleye, Meng Wu, Linda S Efferen, et al.
Pageof 45

Showing results (301-310 of 445) with videos related to

Sort By:
Pageof 45
Annals of Vascular Surgery|March 13, 2025
Use of Suboptimal Great Saphenous Vein in Lower-Extremity Bypass Yields Favorable Amputation-Free SurvivalColin M Cleary, James Gallagher, Parth Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)C P Duffy, C J Elliott, R A O'Connor, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|March 19, 2015
Changes in medical students' exposure to and attitudes about drug company interactions from 2003 to 2012: a multi-institutional follow-up surveyFrederick S Sierles, Kenneth H Kessler, Matthew Mintz, et al.
Protein Engineering, Design & Selection : PEDS|April 14, 2007
Molecular modeling suggests induced fit of Family I carbohydrate-binding modules with a broken-chain cellulose surfaceMark R Nimlos, James F Matthews, Michael F Crowley, et al.
Eclinicalmedicine|January 11, 2024
Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021)Daneng Li, Yohann Loriot, Adam M Burgoyne, et al.
JAMA|September 8, 2005
Medical students' exposure to and attitudes about drug company interactions: a national surveyFrederick S Sierles, Amy C Brodkey, Lynn M Cleary, et al.
Schizophrenia Research|September 29, 2014
A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolismBrenda Vincenzi, Shannon Stock, Christina P C Borba, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2023
Replicative stress in gastroesophageal adenocarcinoma is associated with chromosomal instability and sensitivity to DNA damage response inhibitorsPranshu Sahgal, Deepa T Patil, Zsofia M Sztupinszki, et al.
Annals of Vascular Surgery|October 17, 2025
Utilization of Subsidized Transportation Services Improves Wound Healing and Care Coordination in a Limb Preservation ProgramColin M Cleary, Elizabeth Aitcheson, Darren Courtright, et al.
Journal of Community Health|June 29, 2023
Newly Acquired Burnout During the Coronavirus Disease 2019 (COVID-19) Pandemic: A Retrospective Cohort Study on the Experiences of New York State Primary Care CliniciansDean Akinleye, Meng Wu, Linda S Efferen, et al.
Pageof 45